Viewing Study NCT01769768


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-04 @ 6:21 AM
Study NCT ID: NCT01769768
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2013-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid … View